We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $813M
1-Year Est. Return 37.92%
This Fund
S&P 500
This Quarter Est. Return
+14.62%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+676.44%
AUM
$349M
AUM Growth
+$35.9M
Cap. Flow
-$1.69M
Cap. Flow %
-0.48%
Top 10 Hldgs %
45.54%
Holding
111
New
11
Increased
31
Reduced
53
Closed
7

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$4.13M
2
RTX icon
RTX Corp
RTX
+$2.8M
3
ETN icon
Eaton
ETN
+$2.75M
4
GS icon
Goldman Sachs
GS
+$2.61M
5
CVS icon
CVS Health
CVS
+$1.2M

Sector Composition

Rank Sector Weight
1 Technology 25.18%
2 Consumer Discretionary 17.89%
3 Communication Services 12.29%
4 Financials 10.68%
5 Healthcare 5.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
51
Coca-Cola
KO
$376B
$1.74M 0.5%
35,218
-299
-0.8% -$14.4K
SCHV
52
Schwab US Large-Cap Value ETF
SCHV
$16.3B
$1.73M 0.5%
99,573
+4,689
+5% +$82K
INTC icon
53
Intel
INTC
$527B
$1.7M 0.49%
32,784
-645
-2% -$33.5K
XLK icon
54
State Street Technology Select Sector SPDR ETF
XLK
$125B
$1.68M 0.48%
28,784
-1,222
-4% -$69K
BA icon
55
Boeing
BA
$182B
$1.38M 0.39%
8,338
-219
-3% -$37.3K
TDOC icon
56
Teladoc Health
TDOC
$1.26B
$1.33M 0.38%
6,048
+388
+7% +$82.2K
TIP icon
57
iShares TIPS Bond ETF
TIP
$14.7B
$1.25M 0.36%
9,853
IWM icon
58
iShares Russell 2000 ETF
IWM
$82.4B
$1.24M 0.36%
8,279
-128
-2% -$19.3K
SCHP icon
59
Schwab US TIPS ETF
SCHP
$16.2B
$1.16M 0.33%
37,634
+2,668
+8% +$81.7K
SCHM icon
60
Schwab US Mid-Cap ETF
SCHM
$15.3B
$1.12M 0.32%
60,528
-2,937
-5% -$54.4K
PENN icon
61
PENN Entertainment
PENN
$2.53B
$1.05M 0.3%
14,392
-18,650
-56% -$915K
ABT icon
62
Abbott
ABT
$193B
$962K 0.28%
8,840
+355
+4% +$36K
SCHR
63
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$930K 0.27%
31,710
-818
-3% -$24K
HON icon
64
Honeywell
HON
$74.2B
$844K 0.24%
5,440
CVX icon
65
Chevron
CVX
$388B
$809K 0.23%
11,231
-722
-6% -$60.7K
FLRN icon
66
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.97B
$776K 0.22%
25,353
-698
-3% -$21.3K
TNDM icon
67
Tandem Diabetes Care
TNDM
$1.61B
$776K 0.22%
6,840
-10,365
-60% -$1.09M
NFLX icon
68
Netflix
NFLX
$326B
$753K 0.22%
15,050
+700
+5% +$34.8K
TTWO icon
69
Take-Two Interactive
TTWO
$45.2B
$708K 0.2%
4,288
+630
+17% +$102K
VAR
70
DELISTED
Varian Medical Systems, Inc.
VAR
$688K 0.2%
4,000
DIA icon
71
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.3B
$651K 0.19%
2,345
-105
-4% -$28.7K
MMM icon
72
3M
MMM
$94.2B
$639K 0.18%
4,772
IEX icon
73
IDEX
IEX
$17.6B
$635K 0.18%
3,480
RKT icon
74
Rocket Companies
RKT
$42.6B
$621K 0.18%
+31,160
New +$727K
XOM icon
75
ExxonMobil
XOM
$652B
$616K 0.18%
17,930
-742
-4% -$30.3K

Similar funds

Fagan Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Fagan Associates held 111 positions worth $349M, up 11% from $313M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Fagan Associates's Q3 2020 filing shows 11 new, 31 increased, 53 reduced and 7 closed positions. Its largest new stake was Defiance Space and Connective Tech ETF: 119,645 shares worth $3.41M. The largest sale was Berkshire Hathaway Class B, an estimated $4.13M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Fagan Associates's largest Q3 2020 buy was Defiance Space and Connective Tech ETF: 119,645 shares worth $3.41M.
  • Fagan Associates added most to ARK Genomic Revolution ETF in Q3 2020, an estimated $1.45M increase.
  • Fagan Associates's biggest Q3 2020 reduction was Berkshire Hathaway Class B, cutting an estimated $4.13M.
  • Fagan Associates fully exited RTX Corp in Q3 2020, selling an estimated $2.8M.
  • Fagan Associates's ten largest holdings make up 46% of its $349M portfolio in Q3 2020.
  • Fagan Associates opened 11 new positions and closed 7 in Q3 2020.
  • Fagan Associates's portfolio value rose 11% quarter-over-quarter to $349M.

Based on Fagan Associates's 13F filing for Q3 2020, filed 2 Nov 2020.